Protagonist Therapeutics Inc (PTGX) Stock Is Emerging from the Clouds

CapitalOne raised the price target for the Protagonist Therapeutics Inc (NASDAQ:PTGX) stock to “an Overweight”. The rating was released on October 30, 2023, according to finviz. We previously noted in another research note published on May 25, 2023 by Jefferies that resumed the stock to a Buy with a price target of $40 for PTGX […]

The future of Protagonist Therapeutics Inc (PTGX) Stock is still in tatters?

CapitalOne raised the price target for the Protagonist Therapeutics Inc (NASDAQ:PTGX) stock to “an Overweight”. The rating was released on October 30, 2023, according to finviz. We previously noted in another research note published on May 25, 2023 by Jefferies that resumed the stock to a Buy with a price target of $40 for PTGX […]

Why Protagonist Therapeutics Inc (NASDAQ:PTGX) Stock Jumped 0.81% in Last Month?

CapitalOne raised the price target for the Protagonist Therapeutics Inc (NASDAQ:PTGX) stock to “an Overweight”. The rating was released on October 30, 2023, according to finviz. We previously noted in another research note published on May 25, 2023 by Jefferies that resumed the stock to a Buy with a price target of $40 for PTGX […]